Omega Therapeutics (OMGAQ) Earnings Date & Reports

Omega Therapeutics Inc is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, known as Omega Epigenomic Controllers... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

OMGAQ is expected to report earnings to fall 13.33% to -25 cents per share on May 30

Omega Therapeutics OMGAQ Stock Earnings Reports

Q1'25

Est.

$-0.26

Q4'24

Missed

by $0.07

The last earnings report on March 31 showed earnings per share of -30 cents, missing the estimate of -22 cents. With 411.20K shares outstanding, the current market capitalization sits at 2.05M.

View a ticker or compare two or three

Compare

OMGAQ